← Back to All Filings

Medtronic Director & Officer Geoffrey Martha Proposes $4.75M Share Sale

Medium SignificanceOctober 15, 2026 at 2:11:47 PM UTC

Medtronic plc

$MDT144CIK: 0001613103

Subscribe to track MDT

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📋 Form 144 Notice of Proposed Sale: Medtronic plc ($MDT) Insider: Geoffrey Martha (Officer / Director) Shares to Sell: 50,000 Common Shares Aggregate Market Value: $4,750,000.00 (~$95.00/share) Broker: Fidelity Brokerage Services LLC Plan Details: 10b5-1 trading plan adopted on 07/16/2026.

Comprehensive Analysis

Executive Summary

On October 15, 2026, Geoffrey Martha, Officer and Director of Medtronic plc ($MDT), filed a Form 144 notice proposing the sale of 50,000 common shares through Fidelity Brokerage Services LLC. The estimated aggregate market value of the proposed transaction is $4,750,000.00, representing an implied share price of $95.00.

Transaction Details

  • Securities to be Sold: 50,000 Common shares.
  • Aggregate Market Value: $4,750,000.00.
  • Approximate Sale Date: October 15, 2026.
  • Source of Shares: The shares to be sold originated from a combination of restricted stock vestings between August 2018 and August 2023 (45,443 shares) and a stock option exercise on January 27, 2025 (4,557 shares).
  • Trading Plan: The proposed sale is executed pursuant to a Rule 10b5-1 trading plan adopted on July 16, 2026.

Market & Context

  • Market Impact: The 50,000 shares represent an insignificant fraction (<0.01%) of Medtronic plc's 1,279,137,890 total shares outstanding.
  • Trading Significance: Rated Medium. While the size is immaterial relative to total shares outstanding and executed under a pre-established Rule 10b5-1 trading plan, transactions by top leadership remain an area of interest for institutional investors and governance watchers.
Topics:#MDT#Medtronic#InsiderSelling#Form144#MedTech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.